Perceptions and attitudes are primary contributors to insulin delivery system satisfaction in people with type 2 diabetes

Diabetes Technology and Therapeutics

Volumn 11, Issue 7, 2009, Pages 419-426

  Hayes, Risa P ^a   Fitzgerald, James T ^b  

^a ELI LILLY AND COMPANY   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; DRUG DELIVERY SYSTEM; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DELIVERY SYSTEM; INSULIN PEN; INSULIN TREATMENT; INTERNET; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SATISFACTION; PREDICTION; PRIORITY JOURNAL; SELF INJECTION; SELF REPORT; SYRINGE; ATTITUDE TO HEALTH; BLOOD; DEPRESSION; DIABETIC NEPHROPATHY; DRUG ADMINISTRATION; HEALTH SURVEY; INCIDENCE; MIDDLE AGED; PERCEPTION; PSYCHOLOGICAL ASPECT; STATISTICS; UNITED STATES;

ATTITUDE TO HEALTH; DEPRESSION; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DRUG ADMINISTRATION SCHEDULE; DRUG DELIVERY SYSTEMS; FEMALE; HEALTH SURVEYS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; INSULIN; INTERNET; MALE; MIDDLE AGED; PATIENT SATISFACTION; PERCEPTION; UNITED STATES;

EID: 70349311280     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2008.0123     Document Type: Article

References (42)

1. Koro CE, Bowlin SJ, Bourgeois N, Fedder DO: Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care 2004;27:17-20.
2. Da Costa S, Brackenridge B, Hicks D: A comparison of insulin pen use in the United States and the United Kingdom. Diabetes Educ 2002;28:52-56, 59-60.
3. Flood T: Advances in insulin delivery systems and devices: beyond the vial and syringe. Insulin 2006;1:99-108.
4. Bhargava A: Insulin therapy: the question this issue. Insulin 2007;2:37-39.
5. Magnotti MA, Rayfield EJ: An update on insulin injection devices. Insulin 2007;2:173-181.
6. Stockl K, Ory C, Vanderplas A, Nicklasson L, Lyness W, Cobden D, Chang E: An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe. Curr Med Res Opin 2007;23:133-146.
7. Shelmet J, Schwartz S, Cappleman J, Peterson G, Skovlund S, Lytzen L, Nicklasson L, Liang J, Lyness W; InnoLet Study Group: Preference and resource utilization in elderly patients: InnoLet versus vial=syringe. Diabetes Res Clin Pract 2004;63:27-35.
8. Korytkowski M, Bell D, Jacobsen C, Suwannasari R; FlexPen Study Team: A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial=syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clin Ther 2003;25:2836-2848.
9. Kadiri A, Chraibi A, Marouan F, Ababou MR, el Guermai N, Wadjinny A, Kerfati A, Douiri M, Bensouda JD, Belkhadir J, Arvanitis Y: Comparison of NovoPen 3 and syringes=vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents. Diabetes Res Clin Pract 1998;41:15-23.
10. Coscelli C, Lostia S, Lunetta M, Nosari I, Coronel GA: Safety, efficacy, acceptability of a pre-filled insulin pen in diabetic patients over 60 years old.Diabetes Res Clin Pract 1995;28:173-177.
11. Dunbar JM, Madden PM, Gleeson DT, Fiad TM, McKenna TJ: Premixed insulin preparations in pen syringes maintain glycemic control and are preferred by patients. Diabetes Care 1994;17:874-878.
12. Rubin RR, Peyrot M: Factors affecting use of insulin pens by patients with type 2 diabetes. Diabetes Care 2008;31:430-432.
13. Anderson RT, Marrero D, Skovlund SE, Cramer J, Schwartz S: Self-reported compliance with insulin injection therapy in subjects with type 1 and 2 diabetes [abstract]. Diabetologia 2003;46(Suppl 2):A275.
14. Pladevall M, Williams LK, Potts LA, Divine G, Xi H, Lafata JE: Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care 2004;27:2800-2805.
15. Krapek K, King K, Warren SS, George KG, Caputo DA, Mihelich K, Holst EM, Nichol MB, Shi SG, Livengood KB, Walden S, Lubowski TJ: Medication adherence and associated hemoglobin A1c in type 2 diabetes. Ann Pharmacother 2004;38:1357-1362.
16. Hill-Briggs F, Gary TL, Bone LR, Hill MN, Levine DM, Brancati FL: Medication adherence and diabetes control in urban African Americans with type 2 diabetes. Health Psychol 2005;24:349-357.
17. Rhee MK, Slocum W, Ziemer DC, Culler SD, Cook CB, El-Kebbi IM, Gallina DL, Barnes C, Phillips LS: Patient adherence improves glycemic control. Diabetes Educ 2005; 31:240-250.
18. Odegard PS, Capoccia K: Medication taking and diabetes: a systematic review of the literature. Diabetes Educ 2007; 33:1014-1029; discussion 1030-1031.
19. Rubin RR: Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. Am J Med 2005;118(Suppl 5A):27S-34S.
20. Franciosi M, Pellegrini F, De Berardis G, Belfiglio M, Di Nardo B, Greenfield S, Kaplan SH, Sacco M, Tognoni G, Valentini M, Nicolucci A; The QuED Study Group-Quality of Care and Outcomes in Type 2 Diabetes: Correlates of satisfaction for the relationship with their physician in type 2 diabetic patients. Diabetes Res Clin Pract 2004;66:277-286.
21. Ahlgren SS, Shultz JA, Massey LK, Hicks BC, Wysham C: Development of a preliminary diabetes dietary satisfaction and outcomes measure for patients with type 2 diabetes. Qual Life Res 2004;13:819-832.
22. Hirsch A, Bartholomae C, Volmer T: Dimensions of quality of life in people with non-insulin-dependent diabetes. Qual Life Res 2000;9:207-218.
23. Redekop WK, Koopmanschap MA, Stolk RP, Rutten GE, Wolffenbuttel BH, Niessen LW: Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care 2002;25:458-463.
24. Brod M, Cobden D, Lammert M, Bushnell D, Raskin P: Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analogues. Health Qual Life Outcomes 2007;5:8.
25. Szeinbach SL, Barnes JH, Summers KH, Lenox SM: Development of an instrument to assess expectations of and preference for an insulin injection pen compared with the vial and syringe. Clin Ther 2004;26:590-597.
26. Clinical practice recommendations. Diabetes Care 2008; 31(Suppl 1):S3-S4.
27. Lin EH, Katon W, Von Korff M, Rutter C, Simon GE, Oliver M, Ciechanowski P, Ludman EJ, Bush T, Young B: Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care 2004;27: 2154-2160.
28. Kilbourne AM, Reynolds CF 3rd, Good CB, Sereika SM, Justice AC, Fine MJ: How does depression influence diabetes medication adherence in older patients? Am J Geriatr Psychiatry 2005;13:202-210.
29. Kalsekar ID, Madhavan SS, Amonkar MM, Makela EH, Scott VG, Douglas SM, Elswick BL: Depression in patients with type 2 diabetes: impact on adherence to oral hypoglycemic agents. Ann Pharmacother 2006;40:605-611.
30. Gonzalez JS, Safren SA, Cagliero E, Wexler DJ, Delahanty L, Wittenberg E, Blais MA, Meigs JB, Grant RW: Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care 2007;30:2222-2227.
31. Fisher EB, Thorpe CT, Devellis BM, Devellis RF: Healthy coping, negative emotions, and diabetes management: a systematic review and appraisal. Diabetes Educ 2007;33:1080- 1103; discussion 1104-1106.
32. Padala PR, Desouza CV, Almeida S, Shivaswamy V, Ariyarathna K, Rouse L, Burke WJ, Petty F: The impact of apathy on glycemic control in diabetes: a cross-sectional study. Diabetes Res Clin Pract 2008;79:37-41.
33. McHorney CA, Hayes RP, Bowman L, Myers J: Drivers of treatment preference among individuals with type 2 diabetes [abstract]. Value Health 2004;7:235.
34. Hayes RP, Bowman L, Monahan PO, Marrero DG, McHomey CA: Understanding diabetes medications from the perspective of patients with type 2 diabetes: prerequisite to medication concordance. Diabetes Educ 2006;32:404-414.
35. Nelson KM, McFarland L, Reiber G: Factors influencing disease self-management among veterans with diabetes and poor glycemic control. J Gen Intern Med 2007;22:442-447.
36. Sarkar U, Fisher L, Schillinger D: Is self-efficacy associated with diabetes self-management across race=ethnicity and health literacy? Diabetes Care 2006;29:823-829.
37. Rose M, Fliege H, Hildebrandt M, Schirop T, Klapp BF: The network of psychological variables in patients with diabetes and their importance for quality of life and metabolic control. Diabetes Care 2002;25:35-42.
38. Savoca MR, Miller CK, Quandt SA: Profiles of people with type 2 diabetes mellitus: the extremes of glycemic control. Soc Sci Med 2004;58:2655-2666.
39. O'Connor PJ, Crabtree BF, Yanoshik MK: Differences between diabetic patients who do and do not respond to a diabetes care intervention: a qualitative analysis. Fam Med 1997;29:424-428.
40. Rubin RR, Peyrot M: Quality of life and diabetes. Diabetes Metab Res Rev 1999;15:205-218.
41. Heisler M, Piette JD, Spencer M, Kieffer E, Vijan S: The relationship between knowledge of recent HbA1c values and diabetes care understanding and self-management. Diabetes Care 2005;28:816-822.
42. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-853.